Behbahani Ali

US insider· US
Sign in for alerts
HoldingsTimelineOverlapsAbout
  • REDUCEDT+30

    CRISPR Therapeutics AG · NASDAQ

    −13,679 sh · $780.9K

    Filed 21 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    CRISPR Therapeutics AG · NASDAQ

    +60 sh

    Filed 21 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    CRISPR Therapeutics AG · NASDAQ

    +30,000 sh · $420.0K

    Filed 21 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    CRISPR Therapeutics AG · NASDAQ

    +15 sh

    Filed 21 Sept 2026SEC Form 4view source